Sarepta Therapeutics (SRPT) Enterprise Value (2010 - 2026)
Sarepta Therapeutics' quarterly Enterprise Value came in at -$685.0 million in Q1 2026, down 31.04% year-on-year from -$993.4 million in Q1 2025, and up 19.69% quarter-over-quarter from -$853.0 million in Q4 2025.
Sarepta Therapeutics has reported Enterprise Value for 17 years, with the latest figure at -$685.0 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 31.04% year-over-year to -$685.0 million; the trailing twelve-month figure through Mar 2026 stood at -$685.0 million (down 31.04% YoY), and the FY2025 full-year result was -$853.0 million, up 37.04% from the prior year.
- Enterprise Value for Q1 2026 stood at -$685.0 million, up from -$853.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$522.8 million in Q1 2025, with the low at -$2.1 billion in Q3 2022.
- Average Enterprise Value over 5 years is -$1.4 billion, with a median of -$1.5 billion recorded in 2024.
- Year-over-year, Enterprise Value jumped 62.41% in 2025 and sank 31.04% in 2026.
- Tracing SRPT's Enterprise Value over 5 years: stood at -$2.0 billion in 2022, then increased by 15.74% to -$1.7 billion in 2023, then gained by 19.18% to -$1.4 billion in 2024, then surged by 37.04% to -$853.0 million in 2025, then rose by 19.69% to -$685.0 million in 2026.
- The last three Enterprise Value figures came in at -$685.0 million (Q1 2026), -$853.0 million (Q4 2025), and -$642.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -685.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -685.03 Mn |
| Dec 31, 2025 | -853.02 Mn |
| Sep 30, 2025 | -642.47 Mn |
| Jun 30, 2025 | -800.14 Mn |
| Mar 31, 2025 | -522.76 Mn |
| Dec 31, 2024 | -1.35 Bn |
| Sep 30, 2024 | -1.20 Bn |
| Jun 30, 2024 | -1.46 Bn |
| Mar 31, 2024 | -1.39 Bn |
| Dec 31, 2023 | -1.68 Bn |
| Sep 30, 2023 | -1.73 Bn |
| Jun 30, 2023 | -1.86 Bn |
| Mar 31, 2023 | -1.88 Bn |
| Dec 31, 2022 | -1.99 Bn |
| Sep 30, 2022 | -2.07 Bn |
| Jun 30, 2022 | -1.93 Bn |
| Mar 31, 2022 | -2.01 Bn |
| Dec 31, 2021 | -2.12 Bn |
| Sep 30, 2021 | -1.60 Bn |
| Jun 30, 2021 | -1.73 Bn |
| Mar 31, 2021 | -1.74 Bn |
| Dec 31, 2020 | -1.94 Bn |
| Sep 30, 2020 | -1.82 Bn |
| Jun 30, 2020 | -2.06 Bn |
| Mar 31, 2020 | -2.17 Bn |
| Dec 31, 2019 | -1.12 Bn |
| Sep 30, 2019 | -1.05 Bn |
| Jun 30, 2019 | -1.10 Bn |
| Mar 31, 2019 | -1.34 Bn |
| Dec 31, 2018 | -1.17 Bn |
| Sep 30, 2018 | -792.86 Mn |
| Jun 30, 2018 | -949.14 Mn |
| Mar 31, 2018 | -1.05 Bn |
| Dec 31, 2017 | -1.08 Bn |
| Sep 30, 2017 | -617.63 Mn |
| Jun 30, 2017 | -300.95 Mn |
| Mar 31, 2017 | -390.31 Mn |
| Dec 31, 2016 | -317.85 Mn |
| Sep 30, 2016 | -411.92 Mn |
| Jun 30, 2016 | -59.24 Mn |
| Mar 31, 2016 | -153.53 Mn |
| Dec 31, 2015 | -91.00 Mn |
| Sep 30, 2015 | -99.91 Mn |
| Jun 30, 2015 | -89.09 Mn |
| Mar 31, 2015 | -95.09 Mn |
| Dec 31, 2014 | -210.34 Mn |
| Sep 30, 2014 | -56.30 Mn |
| Jun 30, 2014 | -106.75 Mn |
| Mar 31, 2014 | -225.19 Mn |
| Dec 31, 2013 | -264.22 Mn |
| Sep 30, 2013 | -280.89 Mn |
| Jun 30, 2013 | -163.44 Mn |
| Mar 31, 2013 | -167.92 Mn |
| Dec 31, 2012 | -187.66 Mn |
| Sep 30, 2012 | -37.99 Mn |
| Jun 30, 2012 | -24.49 Mn |
| Mar 31, 2012 | -30.57 Mn |
| Dec 31, 2011 | -39.90 Mn |
| Sep 30, 2011 | -46.36 Mn |
| Jun 30, 2011 | -54.19 Mn |
| Mar 31, 2011 | -23.28 Mn |
| Dec 31, 2010 | -33.59 Mn |
| Sep 30, 2010 | -35.97 Mn |
| Jun 30, 2010 | -36.74 Mn |